BiotechTube
Home/Pipeline/Spinal Cord Injury (SCI) Neural Bridge

Spinal Cord Injury (SCI) Neural Bridge

Spinal Cord Injury

PreclinicalActive

Key Facts

Indication
Spinal Cord Injury
Phase
Preclinical
Status
Active
Company
Matricelf

About Matricelf

Autologous iPSC‑based tissue implants for curative spinal cord injury and broader regenerative medicine.

View full company profile

Therapeutic Areas

Spinal Cord InjuryTraumatic Brain InjuryStrokeMyocardial Infarction

Other Spinal Cord Injury Drugs

DrugCompanyPhase
MSC‑SCIAdvancellsPhase 1
itNSCsStemedica Cell TechnologiesDevelopment
MAP4343MapregPreclinical
Spinal Cord Injury ProgramBioAxone BiosciencesClinical
Undisclosed Scaffold ProgramInnervacePre-clinical
Q-CellsQ TherapeuticsResearch
APOSECAposciencePre-clinical
NG004NeurimmunePhase 1
Perineline™NeuroSolv TherapeuticsPhase 1
Nogo-A Receptor Blocking AntibodyNovaGo TherapeuticsPhase 1b